转录性降低MMP2水平并抑制血管仿真,减缓卵巢癌的进展
在PubMed上查看摘要
概括
此摘要是机器生成的。性别决定区域Y-box 15 (SOX15) 通过抑制血管模拟抑制卵巢癌的进展. SOX15直接抑制矩阵金属蛋白酶-2 (MMP2) 的表达,提供了一个新的治疗点.
科学领域
- 癌症学
- 分子生物学
- 癌症研究
背景情况
- 血管模拟 (VM) 促进瘤生长和入侵卵巢癌.
- 已知性别决定区域Y-box 15 (SOX15) 抑制瘤生长,但其在卵巢癌中的作用尚不清楚.
研究的目的
- 研究SOX15在卵巢癌细胞扩散,入侵和血管模拟中的功能.
- 阐明SOX15在卵巢癌中作用的基础分子机制.
主要方法
- 使用SKOV-3和ES2卵巢癌细胞系和异种移植小鼠模型.
- 评估细胞的增殖,迁移和入侵.
- 测量了VE-cadherin,VEGFA,Ki67和MMP2的表达.
- 进行双化酶报告和ChIP-PCR测试以确定SOX15的作用机制.
主要成果
- 过度表达SOX15抑制了卵巢癌细胞的增殖,迁移和侵入.
- 通过降低VE-cadherin和VEGFA,SOX15减少了VM的形成.
- 在体内增加瘤生长和VM形成.
- SOX15直接抑制了MMP2促进剂的活性和表达.
结论
- 在卵巢癌中,SOX15通过转录抑制MMP2而起瘤抑制作用.
- 通过SOX15/MMP2轴抑制VM形成是一种潜在的卵巢癌治疗策略.
相关概念视频
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

